Orally administered nanocurcumin to attenuate morphine tolerance: Comparison between negatively charged PLGA and partially and fully PEGylated nanoparticles

Molecular Pharmaceutics

Volumn 10, Issue 12, 2013, Pages 4546-4551

  Shen, Hao ^a   Hu, Xiaoyu ^b   Szymusiak, Magdalena ^a   Wang, Zaijie Jim ^b   Liu, Ying ^a,b  

^a University of Illinois at Chicago   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

bioavailability; drug tolerance; oral delivery; pain management; polymeric nanoparticles

Indexed keywords

CURCUMIN; MACROGOL; MORPHINE; POLYGLACTIN; POLYLACTIC ACID; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; ATTENUATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; HOT PLATE TEST; LOADING DRUG DOSE; MALE; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPRAY DRYING; TAIL FLICK TEST;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CURCUMIN; LACTATES; LACTIC ACID; MALE; MICE; MICE, INBRED ICR; MORPHINE; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; POLYMERS; SUSPENSIONS;

EID: 84889258933     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400358z     Document Type: Article

References (22)

1. McQuay, H. Opioids in pain management Lancet 1999, 353 (9171) 2229-2232 (Pubitemid 29295264)
2. Przewlocki, R.; Przewlocka, B. Opioids in chronic pain Eur. J. Pharmacol. 2001, 429 (1-3) 79-91 (Pubitemid 33043984)
3. Rowbotham, M. C.; Twilling, L.; Davies, P. S.; Reisner, L.; Taylor, K.; Mohr, D. Oral opioid therapy for chronic peripheral and central neuropathic pain N. Engl. J. Med. 2003, 348 (13) 1223-1232 (Pubitemid 36359298)
4. Trujillo, K. A.; Akil, H. Inhibition of morphine-tolerance and dependence by the NMDA receptor antagonist MK-801 Science 1991, 251 (4989) 85-87 (Pubitemid 21916858)
5. Sharma, R. A.; Gescher, A. J.; Steward, W. P. Curcumin: The story so far Eur. J. Cancer 2005, 41 (13) 1955-1968 (Pubitemid 41557681)
6. Anand, P.; Kunnumakkara, A. B.; Newman, R. A.; Aggarwal, B. B. Bioavailability of curcumin: Problems and promises Mol. Pharmaceutics 2007, 4 (6) 807-818
7. Matsushita, Y.; Ueda, H. Curcumin blocks chronic morphine analgesic tolerance and brain-derived neurotrophic factor upregulation Neuroreport 2009, 20 (1) 63-68
8. Cole, G. M.; Teter, B.; Frautschy, S. A. Neuroprotective Effects of Curcumin. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease; Springer: New York, 2007; Vol. 595, pp 197-212.
9. Dikshit, P.; Goswami, A.; Mishra, A.; Nukina, N.; Jana, N. R. Curcumin enhances the polyglutamine-expanded truncated N-terminal huntingtin-induced cell death by promoting proteasomal malfunction Biochem. Biophys. Res. Commun. 2006, 342 (4) 1323-1328
10. Lin, J.-A.; Chen, J.-H.; Lee, Y.-W.; Lin, C.-S.; Hsieh, M.-H.; Chang, C.-C.; Wong, C.-S.; Chen, J. J.-Y.; Yeh, G.-C.; Lin, F.-Y.; Chen, T.-L. Biphasic effect of curcumin on morphine tolerance: A preliminary evidence from cytokine/chemokine protein array analysis J. Evidence-Based Complementary Altern. Med. 2011, 1-11
11. Van Eerdenbrugh, B.; Vermant, J.; Martens, J. A.; Froyen, L.; Van Humbeeck, J.; Van den Monter, G.; Augustijns, P. Solubility increases associated with crystalline drug nanoparticles: Methodologies and significance Mol. Pharmaceutics 2010, 7 (5) 1858-1870
12. Kataoka, K.; Harada, A.; Nagasaki, Y. Block copolymer micelles for drug delivery: design, characterization and biological significance Adv. Drug Delivery Rev. 2001, 47 (1) 113-131 (Pubitemid 32209236)
13. Kedar, U.; Phutane, P.; Shidhaye, S.; Kadam, V. Advances in polymeric micelles for drug delivery and tumor targeting Nanomed.-Nanotechnol. Biol. Med. 2010, 6 (6) 714-729
14. Shen, H.; Banerjee, A. A.; Mlynarska, P.; Hautman, M.; Hong, S.; Kapetanovic, I. M.; Lyubimov, A. V.; Liu, Y. Enhanced oral bioavailability of a cancer preventive agent (SR13668) by employing polymeric nanoparticles with high drug loading J. Pharm. Sci. 2012, 101, 3877-3885
15. Shen, H.; Hong, S.; Prud'homme, R. K.; Liu, Y. Self-assembling process of flash nanoprecipitation in a multi-inlet vortex mixer to produce drug-loaded polymeric nanoparticles J. Nanopart. Res. 2011, 13 (9) 4109-4120
16. Banerjee, A. A.; Shen, H.; Hautman, M.; Anwer, J.; Hong, S.; Kapetanovic, I. M.; Liu, Y.; Lyubimov, A. V. Polymeric nanoparticles enhance oral bioavailability of the hydrophobic chemopreventive agent (SR13668) in beagle dogs Curr. Pharm. Biotechnol. 2013, 14, 464-469
17. 2+/calmodulin-dependent protein kinase II J. Pharmacol. Exp. Ther. 2006, 317 (2) 901-909
18. He, Y.; Yang, C.; Kirkmire, C. M.; Wang, Z. J. Regulation of opioid tolerance by let-7 family MicroRNA targeting the mu opioid receptor J. Neurosci. 2010, 30 (30) 10251-10258
19. Wang, Z. J.; Gardell, L. R.; Ossipov, M. H.; Vanderah, T. W.; Brennan, M. B.; Hochgeschwender, U.; Hruby, V. J.; Malan, T. P.; Lai, J.; Porreca, F. Pronociceptive actions of dynorphin maintain chronic neuropathic pain J. Neurosci. 2001, 21 (5) 1779-1786 (Pubitemid 32182217)
20. 2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice J. Pharmacol. Exp. Ther. 1996, 277 (1) 484-490 (Pubitemid 27169095)
21. Tang, L.; Shukla, P. K.; Wang, Z. J. Disruption of acute opioid dependence by antisense oligodeoxynucleotides targeting neurogranin Brain Res. 2007, 1143, 78-82 (Pubitemid 46440819)
22. Liu, Y.; Cheng, C.; Prud'homme, R. K.; Fox, R. O. Mixing in a multi-inlet vortex mixer (MIVM) for flash nano-precipitation Chem. Eng. Sci. 2008, 63 (11) 2829-2842 (Pubitemid 351636094) Medicine